The final approved dosing, if and when retatrutide receives FDA approval, will be determined by the regulatory review process and may differ from the trial protocols
If you are a female or male of reproductive potential: Discontinue compounded semaglutide at least 2 months before a planned pregnancy since the drug can stay in the bloodstream for a long time
If you experience persistent difficulties with injection technique, repeated injection site reactions, or uncertainty about proper administration, contact your prescribing clinician, practice nurse, or community pharmacist
Education around expectations, side effects, and pacing is provided so patients feel informed and prepared
Applicants must have availability on weekdays with some flexibility for evenings and weekends when needed